Correction: Pennisi, R., et al. Hsp90: A New Player in DNA Repair? Biomolecules 2015, 5, 2589–2618

The authors of the published paper [1] wish to add the following two references on pages 2590 and 2597–2598 that were not originally cited in the text, consequently the paper has been updated:

11.

Kaplan, K.B.; Li, R. A prescription for ‘stress’—The role of Hsp90 in genome stability and cellular adaptation. Trends Cell Biol. 2012, 22, 576–583.

105.

Gullotta, F.; De Marinis, E.; Ascenzi, P.; di Masi, A. Targeting the DNA double strand breaks repair for cancer therapy. Curr. Med. Chem. 2010, 17, 2017–2048.

Furthermore, the following references were not correctly cited in the original paper, and have thus been updated:

122.

Fang, Q.; Inanc, B.; Schamus, S.; Wang, X.H.; Wei, L.; Brown, A.R.; Svilar, D.; Sugrue, K.F.; Goellner, E.M.; Zeng, X.; et al. HSP90 regulates DNA repair via the interaction between XRCC1 and DNA polymerase beta. Nat. Commun. 2014, 5, doi:10.1038/ncomms6513.

198.

Tung, C.L.; Jian, Y.J.; Syu, J.J.; Wang, T.J.; Chang, P.Y.; Chen, C.Y.; Jian, Y.T.; Lin, Y.W. Down-regulation of ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 protein (XRCC1) expression by Hsp90 inhibition enhances the gefitinib-induced cytotoxicity in human lung cancer cells. Exp. Cell Res. 2015, 334, 126–135.

The authors apologize to the readers and authors of the cited papers for any inconvenience caused by these changes.